Drug compliance is defined clinically as the degree to which the patient's drug behavior is consistent with clinical treatment and health guidance. Good drug compliance is not only an important factor in rational drug use, but also has an important impact on the clinical efficacy of drugs and the evaluation and decision of clinical drugs. With the continuous development of society and the increasing pressure on people's lives, the coexistence of various diseases has become more common. Different clinical treatment options, drug types, patient age, education level, psychological quality, physical condition, and medical and health knowledge may have an impact on drug compliance, which may affect clinical treatment. Psoriasis is commonly known as psoriasis. To investigate the effects of overall media health education on local drug compliance, health knowledge, compliance, and quality of life in patients with psoriasis, 138 psoriasis patients admitted to the dermatology department over the past two years were selected. According to different treatment methods, they were divided into experimental group (health education group) and regular group (oral education group) to compare the educational effects of the two groups. The experiment proved that after the health education, the health knowledge awareness rate of the experimental group was significantly higher than that of the conventional group. The behavioral rate of the experimental group was significantly higher than that of the conventional group. The DLQI score of the experimental group was significantly lower than that before and after the education. It can be seen that the whole-course health education of patients with psoriasis is of great significance for improving patients' understanding of diseases and compliance with drugs for external use. Health education helps promote patient compliance, adhere to medical practices and improve the quality of life of patients.

Xia Yan. Effect of Whole Media Health Education on the Compliance of External Drug Treatment in Patients with Psoriasis Outpatients. International Journal of Educational Innovation and Science (2021), Vol. 2, Issue 3: 34-45. https://doi.org/10.38007/IJEIS.2021.020305.

[1] Regier, Y., O’Rourke, F., & Kempf, V. A. (2016) “Bartonella Spp.-a Chance to Establish One Health Concepts in Veterinary and Human Medicine”, Parasites & Vectors, 9(1), pp. 261. DOI: 10.1186/s13071-016-1604-4

[2] El Haj, M., Raffard, S., & Gély-Nargeot, M. C. (2016) “Destination Memory and Cognitive Theory of Mind in Normal Ageing”, Memory, 24(4), pp. 526-534.

[3] Dudley, J. J., & Kristensson, P. O. (2018) “A Review of User Interface Design for Interactive Machine Learning”, ACM Transactions on Interactive Intelligent Systems (TiiS), 8(2), pp. 8. DOI: 10.1145/3185517

[4] Secrest, A. M., Asgari, M. M., Kourosh, A. S., Barbieri, J. S., & Albrecht, J. (2017) “Prior Authorizations for Dermatologic Medications: An American Academy of Dermatology Survey of US Dermatology Providers and Staff”, Journal of the American Academy of Dermatology, 77(4), pp. 784-786.

[5] Vender, R., Gooderham, M. J., Guenther, L. C., Kyritsis, D., Rao, J., Kowalczyk, A., & Ashkenas, J. (2018) “Canadian Patients’ Preferences in Topical Psoriasis Care: Insights from the PROPEL Surveys”, Journal of Cutaneous Medicine and Surgery, 22(5), pp. 464-471.

[6] Iversen, L., & Jakobsen, H. B. (2016) “Patient Preferences for Topical Psoriasis Treatments are Diverse and Difficult to Predict”, Dermatology and Therapy, 6(2), pp. 273-285. DOI: 10.1007/s13555-016-0119-4

[7] Cheng, K., Yang, X. Q., Zhang, X. S., Chen, J., An, J., Song, Y. Y. & Song, X. L. (2018) “High‐Security Nanocluster for Switching Photodynamic Combining Photothermal and Acid‐Induced Drug Compliance Therapy Guided by Multimodal Active‐Targeting Imaging”, Advanced Functional Materials, 28(36), pp. 1803118.

[8] Iyengar, A., Lewin, S., & Lantos, J. D. (2018) “Considering Family Resources When Making Medical Recommendations”, Pediatrics, 141(1), pp. e20171198.

[9] Marcinkiewicz, M., & Majewski, S. (2016) “The Role of Antimicrobial Peptides in Chronic Inflammatory Skin Diseases”, Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii, 33(1), pp. 6.

[10] Buggio, L., Lazzari, C., Monti, E., Barbara, G., Berlanda, N., & Vercellini, P. (2017) ““Per Vaginam” Topical Use of Hormonal Drugs in Women with Symptomatic Deep Endometriosis: A Narrative Literature Review”, Archives of Gynecology and Obstetrics, 296(3), pp. 435-444.